Antithombotic Flashcards
(19 cards)
Dyridamole
Cilostazol
Vasodilator, anti platelet
Inhibit adenosine reuptake by rbc and endothelial cells -^ cAMP in platelets
Inhibits Phosphodiesterase -^ camp and cgmp in platelet
Increase PGI-2
-used with aspirin to prevent thromboembolism in prosthetic valves and stroke
Aspirin
Irreversible blocks cOX -no TXA2 decreases platlet aggregation
Low dose prevents MI(spares PGI-2 synthesis)
Disadvantage -gastric bleeding
Clopidrogrel
Prausigrel
Ticoplidine
ADP receptor antagonist
- high oral bioavailability
- less GI bleeding
A.e. Neutropenia, thrombocytopenia, ticlopidibe
Abciximab-monoclonal ab
Tirifiban
Inhibit GP11b/111a-inhibit cross linking aggregation
Use in : acute coronary syndrome** coronary angioplasty
Can be given with heparin /and aspirin
Heparins
Vitamin k antagonist
Direct thrombin inhibitors
Anticoagulants
Heparin
Water soluble -short half life-not orally,controlled by PTT
Heterogenous polysaccharide
^ activity of endogenous anticoagulant anti thrombin III
- inhibits factors Xa, IXa, XIa
-Does not cross placenta
A.e. Bleeding, thrombocytopenia , osteoporosis , alopecia
Enoxaparin
Dalteparin
Tinzapatin
Low molecular weight heparin
Selectivity inhibit factor Xa
Longer half life
Lower risk A.e. Of osteoporosis or thrombocytopenia
Heparin antagonist-for heparin bleeding
Protamine sulfate
Given IV -1mg for 100 units if heparin
Works better in regular heparin
Protamine sulfate
Heparin antagonist
Fondaparinux
Direct factor Xa inhibitor
Synthetic pentasaccharide
Low risk-thrombocytopenia
Lepirudin
Argatroban
Bivalirudin
Direct thrombin inhibitors
For patients with heparin induced thrombocytopenia
Warfarin
Vitamin k antagonist -inhibits 2,7,9,10, (works in liver)
Inhibits protein c
Long half life-given orally
Controlled by PT INR
A.e. Alopecia, bleeding, skin necrosis, purple toes,fetal warfarin syndrome
Warfarin overdose
Vitamin k
Frozen plasma
Plasma concentrates 2,7,9,10
Streptokinase
Antigenic
Non fibrin specific
Half life specific-
A.e. Hypersensitivity
Binds circulating plasminogen changes it to plasmin
Aprotinin
Inhibition of fibrinolysis
Inhibits plasmin and Kalikrein
Aminocaproic acid
Tranexamic acid
Acts by binding plasminogen and inhibits it’s activation to plasmin
Tpa
Binds to fibrin bound plasminogen
Localized action
Fibrinolytic
Ateplace
Reteplace
DNA recombinant T-pa
Non antigenic
Fibrin specific
Half life-10 minutes
Fibrinolytic drug
Side effect of heparin
Alopecia hairless
Bleeding
thrombocytopenia
Osteoporosis